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reliable communication and consistent goals. The second 
challenge was to provide a province-wide repository for sharing 
information and facilitating communication. In parallel with 
addressing these challenges, developmental work on 
streamlining and standardizing the RT process occurred. 
Results: The initial SC was assembled in Q1 2015; and full 
assembly of the SC and CG was completed in Q1 2016. The CG 
meets virtually on a weekly basis. The SC meets every ~6 weeks. 
Every second SC meeting is face-to-face at alternating RT centre 
locations. A Sharepoint site, accessible both inside and outside 
the organizational network, provides a central repository for 
information. RT process developments to-date include: 1) 
standard use of ARIA RO V11 MR 5.2 Prescribed Treatment 
workspace; 2) the entry of Diagnosis and Staging in ARIA RO; 3) 
standard definitions for a number of variables in our provincial 
minimum dataset; and 4) generation of an End of Treatment 
summary in ARIA RO with future distribution to other systems. 
Conclusions: The participation of all disciplines and facilities 
involved in the radiotherapy process is essential. Collaboration 
and communication between the four RT centres has greatly 
improved because of this project. North and South ARIA RO are 
now utilizing the same software versions and are converging in 
processes, carepaths, and definitions. The SC and CG provide a 
radiation oncology voice for communication with other provincial 
cancer control and healthcare initiatives. 
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Purpose: In 2011 the Canadian Partnership for Quality 
Radiotherapy (CPQR) released Quality Assurance Guidelines for 
Canadian Radiation Treatment Programs (QRT) recommending 
key quality indicators (KQI) of high quality, safe radiotherapy 
(RT). As it is unknown to what degree radiation oncology 
programs (ROP) use the guideline or meet these KQIs, we 
conducted a survey of Canadian ROPs to ascertain current 
guideline use and perceived barriers to its use as a self-auditing 
quality improvement (QI) tool.  
Methods and Materials: An invitation to participate was sent May 
2015 to all Canadian ROPs through their local CPQR 
representatives requesting one response per ROP (completed by 
December 2015). Each ROP was asked about use of the QRT 
document comprised of 47 KQI: 34 KQI scored as 0 (no) or1 (yes), 
and 13 KQI scored as a continuous variable of percentage 
compliance. To inquire about perceived barriers to unmet KQIs, 
personalized surveys were issued to each ROP based on results of 
their submitted self-audit of guideline KQIs.  
Results: The majority of ROPs completed the requested 
guideline self-audit (n = 44/45, 98%), with most (75%, 33/44) 
indicating previous use of the QRT. ROPs in the Prairies and 
Quebec accounted for 82% of centres (9/11) reporting no 
previous QRT use. Across ROP, there was a range of compliance 
for the 34 KQI scorable as 0 (no) or 1 (yes) (median 31/34, range 
19-34). Those binary KQIs identified as the most challenging 
included #22 (frequent policy and procedure review) with 50% 
compliant ROP (22/44) and #17 (RTQAC monitoring of technical 
quality control) with 66% compliant ROP (29/44). All 44 
responding ROP reported compliance with the following KQI: #32 
(RT prescription), #39 (on RT patient evaluation), #41 
(emergency RT policies/procedures) and #42 (RT plan record 
maintenance). Of the KQIs scored as a continuous variable, 
compliance was highest (100% median, range 60-100%) for #10 
(radiation oncologist certification) and lowest (median 50%, 
range 10-100%) for #33 (peer review pre-RT start). Two KQI 
appear particularly challenging, with only 59% (26/44) and 57% 
(25/44) of ROP responding regarding #44 (toxicity outcomes, 
median 30% ROP score, range 0-100%) and #45 (disease 
control/survival outcomes, median 25% ROP score, range 0-
100%), respectively. Commonly perceived barriers included lack 
of resources, data tracking ability or even disagreement with 
certain KQI. Many centres reported progress with unfulfilled 
KQIs, of which #2 and #3 (RTQAC monitoring and terms of 
reference) were most commonly cited. 
Conclusions: Since initial release of CPQR QRT, the majority of 
Canadian ROPs have used the guideline at least once to perform 
a quality self-audit. There are, however, gaps in guideline use 
and variations among centres in terms of KQI compliance. Future 
studies of potential facilitators to KQI uptake are warranted, as 
knowledge of perceived barriers may inform future strategies for 
optimizing QI initiatives across Canadian ROP. 
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CANADIAN CANCER CENTRES ARE STRUGGLING TO INVEST IN 
DEVELOPMENT OF FUTURE LEADERS: RESULTS OF A PAN 
CANADIAN SURVEY  
Peter Craighead
Tom Baker Cancer Centre, Calgary, AB
 
Purpose: To evaluate leadership models in Canadian cancer 
centres, and assess leadership development programs within 
these centres.  
Methods and Materials: This mixed methods health services 
study was performed between August and October 2015 by the 
leadership of a Canadian cancer centre. It used literature 
review, a pan-Canadian survey and structured interviews with 
fifty administrative leads of free standing cancer centres 
registered with the Canadian Association of Provincial Cancer 
Agencies (40 invited to complete a written survey; 10 phone 
interviews). The survey consisted of 26 questions organized 
into categories such as: rating of current leadership; 
important elements of leadership; traits that identify emerging 
leaders; the use of competency frameworks to evaluate 
leaders and the availability of programs to improve skills in 
leaders. 
Results: Twenty three of the potential 50 participants (46%) 
provided responses including representation from all provinces. 
Synthesis of responses provided the following insights: 1) there 
is strong consensus about the effectiveness of current leaders 
and which elements of leadership are considered important; 2) 
good agreement was reached on the traits that identify emerging 
leaders; 3) it was clear that competency frameworks are not 
employed consistently. Fewer than 70% of respondents used the 
LEADS tool to evaluate their leaders; and 4) none of the 
respondents used formal succession planning tools. 75% of 
respondents did not systematically offer skill development 
programs to their leaders.  
Conclusions: Although current leaders are perceived as doing 
well at leading, there seemed to be several gaps needing 
attention. Firstly, there does not appear to be a consistent 
expectation of leaders needing to be regularly evaluated. 
Secondly, it is concerning that administrative and medical 
leaders within a significant number of Canadian cancer centres 
do not see the importance of providing opportunities to leaders 
that would maximize their skills to lead teams or drive innovative 
change. For cancer programs to thrive there needs to be greater 
attention to develop emerging leaders. 
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Purpose: Develop an evidence-based decision-support 
framework for optimizing the location of Radium 223 (Ra) 
treatment facilities based on different metrics of geographic 
access. 
Methods and Materials: Residence at death and death date for 
all patients who died of prostate cancer in British Columbia 
between 2009 and 2014 were obtained from a prospectively 
maintained population-based registry. Patients who died of 
prostate cancer were considered potentially eligible for Ra 
treatment prior to death, assuming that they would go through 
a phase of symptoms from bone metastases. Forty-percent of 
patients in the province are known to receive palliative 
radiotherapy to bone prior to death from prostate cancer. Two 
metrics of geographic access were defined: average travel time 
to a treatment facility (ATT) and percentage of patients residing 
within 90 minutes travel to a treatment facility (C90). At the 
time of analysis, three nuclear medicine facilities were providing 
Ra (Vancouver, Victoria and Kelowna). All 22 other licensed 
nuclear medical facilities in the province were considered as 
feasible new locations for Ra treatment. Travel time from each 
patient’s residence to every facility was calculated using 
Microsoft MapPoint. An integer programming model was 
developed to find the facility locations that optimize ATT and 
C90. C90 was considered primary metric as ATT tends to 
overweight a small number of cases with very long travel times. 
Results: 3194 patients met eligibility criteria. Several scenarios 
seeking to improve geographic access by choosing different 
locations for Ra treatment were run. The first group of scenarios 
considered the existing locations and tested the addition of new 
locations from the nuclear medical facilities. Prior to death, 67% 
of patients lived within 90 minutes of one of the three centres 
currently providing Ra. C90 increased to 75%, 79%, and 82% when 
one, two and three additional facilities were added. ATT 
decreased from 156 minutes to 89, 79 and 70 minutes 
respectively. The additional facilities (mid-Vancouver Island, 
Kamloops and eastern Fraser Valley successively) were in areas 
with medium-high population density and long distances to the 
existing Ra facilities. To reach a C90 of 90%, a total of seven 
additional facilities would have to be opened. A second group of 
scenarios assumed a “greenfield” setting with no pre-existing 
facilities. Resulting facility locations differed from the existing 
locations and improved C90 to 70%, 78%, 82% and 85% with three, 
four, five and six Ra treatment facilities. 
Conclusions: Geographic access is one of the important factors 
to consider when deciding the location of treatment facilities. 
By measuring geographic access and determining optimal 
location of new facilities, the proposed framework provides a 
data-driven approach to quantitatively evaluate the 
configuration of a treatment delivery system. This framework 
can be expanded to include other clinical, operational and 
political considerations. 
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Purpose:  With increasing incidence and prevalence of cancer in 
Canada and beyond, the use of radiation therapy (RT) for both 
curative and palliative intents will continue to increase. 
Combined with the unprecedented pace of technological 
innovation and increasing complexity of care, the RT system 
must find new models of care to rethink the distribution of work 
and the skill sets required to do this work. In Ontario, the Clinical 
Specialist Radiation Therapy (CSRT) Project was created to 
ascertain if advanced practice radiation therapists (APRT) could 
add effectiveness and efficiency to the already burdened system 
in a value-added way. Since 2004, the project team has 
developed, implemented and evaluated the APRT role in a 
variety of clinical settings. 
Methods and Materials: After a period of time allotted to allow 
the pilot APRTs to acquire and prove competence in activities 
specific to their particular positions, mixed methods were used 
to test the impact of redistributing workload between APRTs and 
radiation oncologists (RO) under the headings of: 1) Quantity - 
ability to increase capacity at point of entry to the system 
(direct) and within the care pathway (indirect); 2) Quality - 
improvement in provision of patient care or addition of new 
services to improve the patient experience and/or satisfaction; 
and 3) Innovation and Knowledge Translation – the volume of 
research and innovation activities that include or are being led 
by APRTs. 
Results: In the 2014-2015 year, there were 24 CSRT “active” 
positions in place, with 21 of them being considered permanent 
full-time (CCO, 2015). Under the heading of Quantity, many 
positive direct and indirect impacts have been reported with the 
addition of CSRTs including: an increase in the number of new 
patients seen in consult (direct) and the number of RO hours 
saved (indirect). The reported number of additional patients 
seen was as high as 28 new patients per month (33% increase; 
average: 20%) and the reported number of RO hours saved were 
as high as 50 hours per month (average: 12.5 hours) which, at its 
maximum, represents a significant amount of ROs’ time 
allocated to clinical work and patient care (CCO, 2015).  
Conclusions: The CSRT-driven model of care can provide 
significant added value to the existing RT system by adding 
capacity for an increased number of patients to enter the system 
and for ROs to focus on more complex activities in their scope. 
It is suggested that this model should be considered a viable 
option for managing the pressures of the changing landscape in 
RT in Canada. 
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Purpose: Adjuvant breast radiotherapy (RT) is a standard 
treatment option in women with early-stage breast cancer 
following lumpectomy. Timeliness of RT treatment can impact 
patient satisfaction. The objectives of this study are to assess: 
1) patient satisfaction of their whole breast RT; 2) patient
preference for timing of RT start after CT simulation (CTSim); 
and 3) factors that influence patient stress and quality of life. 
Methods and Materials: Women undergoing whole breast RT 
were given a survey before RT treatment and at treatment 
completion. Patients were offered treatment either through the 
conventional process (ConvProcess), where RT starts typically 
within 1-2 weeks of CTSim, or the QuickStart (QS) process, where 
RT starts one day after CTSim. The pre-treatment (PRE-Tx) 
survey included questions to understand the social impact of RT, 
and the post-treatment (POST-Tx) survey included questions 
relating to social climate and patient satisfaction. Questions 
relating to RT start preference, stress (Perceived Stress Scale 
[PSS]) and quality of life (Illness Intrusiveness Ratings Scale 
[IIRS]), were assessed both at PRE-Tx and POST-Tx. An analysis 
of covariance was used to determine if the RT process impacted 
PSS and IIRS, and t-tests were used as a secondary analysis. 
Fisher’s Exact test was used where appropriate. 
Results: Ninety-six patients completed the PRE-Tx survey and 88 
completed both surveys (QS process n = 28; ConvProcess n = 60). 
All patients indicated they had a positive experience with the RT 
